A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy
Top Cited Papers
- 1 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Nanotechnology
- Vol. 15 (12), 1043-U92
- https://doi.org/10.1038/s41565-020-00781-4
Abstract
A fluoropolymer-based cancer nanovaccine that delivers antigens directly to the cytosol of dendritic cells and elicits strong antitumour immune responses inhibiting tumour growth in animal models can be used to produce personalized treatment for post-surgical immunotherapy. Cancer metastases and recurrence after surgical resection remain an important cause of treatment failure. Here we demonstrate a general strategy to fabricate personalized nanovaccines based on a cationic fluoropolymer for post-surgical cancer immunotherapy. Nanoparticles formed by mixing the fluoropolymer with a model antigen ovalbumin, induce dendritic cell maturation via the Toll-like receptor 4 (TLR4)-mediated signalling pathway, and promote antigen transportation into the cytosol of dendritic cells, which leads to an effective antigen cross-presentation. Such a nanovaccine inhibits established ovalbumin-expressing B16-OVA melanoma. More importantly, a mix of the fluoropolymer with cell membranes from resected autologous primary tumours synergizes with checkpoint blockade therapy to inhibit post-surgical tumour recurrence and metastases in two subcutaneous tumour models and an orthotopic breast cancer tumour. Furthermore, in the orthotopic tumour model, we observed a strong immune memory against tumour rechallenge. Our work offers a simple and general strategy for the preparation of personalized cancer vaccines to prevent post-operative cancer recurrence and metastasis.This publication has 41 references indexed in Scilit:
- A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratiosNature Communications, 2014
- Self-assembled magnetic filter for highly efficient immunomagnetic separationLab on a Chip, 2010
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic CorrelatesJournal of Clinical Oncology, 2010
- The effects of IL-6 on CD4 T cell responsesClinical Immunology, 2009
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Cancer immunotherapy: moving beyond current vaccinesNature Medicine, 2004
- Helping the CD8+ T-cell responseNature Reviews Immunology, 2004
- Bafilomycin A1 Prevents Maturation of Autophagic Vacuoles by Inhibiting Fusion between Autophagosomes and Lysosomes in Rat Hepatoma Cell Line, H-4-II-E Cells.Cell Structure and Function, 1998
- Signals and signs for lymphocyte responsesCell, 1994
- Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.Proceedings of the National Academy of Sciences of the United States of America, 1989